J. Goldman & Co LP - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$212,00040,0000.03%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$9,930,0003.10%
NEA Management Company, LLC 1,766,779$12,562,0001.04%
Samsara BioCapital, LLC 186,540$1,326,0000.90%
GREAT POINT PARTNERS LLC 1,288,093$9,158,0000.84%
Bpifrance SA 1,078,670$7,669,0000.83%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$1,264,0000.58%
ADAMS STREET PARTNERS LLC 367,935$2,616,0000.52%
Prosight Management, LP 52,051$370,0000.20%
GMT CAPITAL CORP 53,419$380,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 38,881$276,0000.00%
View complete list of MILLENDO THERAPEUTICS INC shareholders